Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGD Peptide Hydrogel with M-MIST for Periodontal Intrabony Defects
NCT05653245Phase 2Completed
- Sponsor
- Minia University
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of arginylglycylaspartic acid in periodontitis, sponsored by Minia University. Started Mar 2021; status: completed.
02
Drugs
arginylglycylaspartic acid
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05653245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05653245.